enGene Therapeutics Inc. Warrants (ENGNW)

Typically moves ±10.39% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-12-18 ESTIMATED
search

enGene Therapeutics Inc. Warrants (ENGNW) has a 11-report earnings history dating back to Mar 11, 2024. Its average absolute post-earnings move is ±10.39%, and 100.0% of those reactions were positive. Its largest post-earnings gain was +114.29% (Jun 15, 2026) and its largest decline was +0% (Sep 08, 2026). The next earnings report is predicted for 2026-12-18 (estimated).

Earnings reactions

How ENGNW moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

11

Avg Abs. Movement

±10.39%

Positive %

100.0%

Negative %

0.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Sep 08, 2026 ☀ PRE +0% open_in_new
Jun 15, 2026 ☀ PRE +114.29% open_in_new
Mar 09, 2026 ☀ PRE +0% open_in_new
Dec 22, 2025 ☽ POST +0% open_in_new
event

Earnings Count

11

Total earnings in dataset

trending_up

Avg Abs. Movement

±10.39%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 9 →
9
Funds holding
$6165686
Total value held
Buying
9 added · 0 reduced
Ameriprise Financial Inc
$4629266 NEW BUY
Ubs Group Ag
$880721 NEW BUY
Barclays Plc
$488751 NEW BUY
Morgan Stanley
$57239 NEW BUY
Raymond James Financial Inc
$36946 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
10-Q 20260908 open_in_new SEC.gov
8-K 20260908 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260813 open_in_new SEC.gov
SCHEDULE 13G/A 20260812 open_in_new SEC.gov
8-K 20260811 open_in_new SEC.gov
3 20260722 open_in_new SEC.gov
3 20260722 open_in_new SEC.gov

Frequently asked about ENGNW earnings

When does enGene Therapeutics Inc. Warrants report earnings next? expand_more

enGene Therapeutics Inc. Warrants (ENGNW)'s next earnings date is estimated for 2026-12-18. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ENGNW stock move after earnings? expand_more

Over 11 reports, ENGNW has moved an average of ±10.39% the session after earnings, closing higher 100.0% of the time.

What was ENGNW's biggest post-earnings move? expand_more

ENGNW's largest post-earnings gain on record was +114.29% on Jun 15, 2026, and its largest decline was +0% on Sep 08, 2026.

Where can I find enGene Therapeutics Inc. Warrants's SEC filings? expand_more

All of enGene Therapeutics Inc. Warrants's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers